Hermann Tenor

1.3k total citations
26 papers, 1.1k citations indexed

About

Hermann Tenor is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Hermann Tenor has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Physiology. Recurrent topics in Hermann Tenor's work include Phosphodiesterase function and regulation (16 papers), Asthma and respiratory diseases (10 papers) and Pulmonary Hypertension Research and Treatments (6 papers). Hermann Tenor is often cited by papers focused on Phosphodiesterase function and regulation (16 papers), Asthma and respiratory diseases (10 papers) and Pulmonary Hypertension Research and Treatments (6 papers). Hermann Tenor collaborates with scholars based in Germany, France and Switzerland. Hermann Tenor's co-authors include Armin Hatzelmann, Rolf Beume, Christian Schudt, Esteban Morcillo, Serge Adnot, Shahin Sanjar, Giuseppe Lungarella, Julio Cortijo, Janis K. Shute and Martin K. Church and has published in prestigious journals such as PLoS ONE, Circulation Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hermann Tenor

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hermann Tenor Germany 18 587 405 385 221 140 26 1.1k
Rolf Beume Germany 15 679 1.2× 618 1.5× 533 1.4× 221 1.0× 148 1.1× 28 1.2k
Manjula Karpurapu United States 20 606 1.0× 174 0.4× 167 0.4× 471 2.1× 77 0.6× 38 1.2k
Shinji Sakaue Japan 13 503 0.9× 700 1.7× 522 1.4× 201 0.9× 78 0.6× 22 1.5k
Suchita Singh India 12 461 0.8× 258 0.6× 236 0.6× 133 0.6× 37 0.3× 21 1.0k
Zouher Majd France 15 864 1.5× 231 0.6× 77 0.2× 192 0.9× 158 1.1× 24 1.5k
Marco Failla Italy 10 240 0.4× 271 0.7× 360 0.9× 115 0.5× 26 0.2× 12 763
Ernst Wm. Spannhake United States 16 488 0.8× 180 0.4× 119 0.3× 230 1.0× 83 0.6× 25 896
Yunbiao Lu United States 14 660 1.1× 215 0.5× 133 0.3× 220 1.0× 32 0.2× 17 1.3k
Ayaka Kinoshita Japan 15 531 0.9× 207 0.5× 102 0.3× 505 2.3× 109 0.8× 45 1.8k
Lei Xue China 20 474 0.8× 68 0.2× 206 0.5× 133 0.6× 56 0.4× 56 1.0k

Countries citing papers authored by Hermann Tenor

Since Specialization
Citations

This map shows the geographic impact of Hermann Tenor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermann Tenor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermann Tenor more than expected).

Fields of papers citing papers by Hermann Tenor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermann Tenor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermann Tenor. The network helps show where Hermann Tenor may publish in the future.

Co-authorship network of co-authors of Hermann Tenor

This figure shows the co-authorship network connecting the top 25 collaborators of Hermann Tenor. A scholar is included among the top collaborators of Hermann Tenor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hermann Tenor. Hermann Tenor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, You-Seong, et al.. (2025). Patient-convenient long-term alopecia treatment via PLGA microsphere-loaded candlelit microneedles. Journal of Materials Chemistry B. 13(20). 5789–5801. 1 indexed citations
2.
Greenwald, Maya Ben‐Yehuda, Weiye Li, Paul Hiebert, et al.. (2022). Topical Wound Treatment with a Nitric Oxide-Releasing PDE5 Inhibitor Formulation Enhances Blood Perfusion and Promotes Healing in Mice. Pharmaceutics. 14(11). 2358–2358. 5 indexed citations
3.
Greenwald, Maya Ben‐Yehuda, Carlotta Tacconi, Natasha Joshi, et al.. (2020). A Dual-Acting Nitric Oxide Donor and Phosphodiesterase 5 Inhibitor Promotes Wound Healing in Normal Mice and Mice with Diabetes. Journal of Investigative Dermatology. 141(2). 415–426. 24 indexed citations
4.
Naef, Reto, Hermann Tenor, & Guido Koch. (2020). TOP-N53: A Clinical Drug Candidate for the Treatment of Non-healing Wounds. CHIMIA International Journal for Chemistry. 74(10). 814–814. 6 indexed citations
5.
Salvator, Hélène, Amparo Buenestado, Marion Brollo, et al.. (2020). Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist. Frontiers in Pharmacology. 11. 598702–598702. 5 indexed citations
6.
Koga, Hiroshi, Andreas Recke, Gestur Vidarsson, et al.. (2016). PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita. Journal of Investigative Dermatology. 136(11). 2211–2220. 18 indexed citations
7.
Victoni, Tatiana, Thomas Gicquel, Hermann Tenor, et al.. (2015). Roflumilast n-oxide associated with PGE2 prevents the neutrophil elastase-induced production of chemokines by epithelial cells. International Immunopharmacology. 30. 1–8. 8 indexed citations
8.
Totani, Licia, Concetta Amore, Giuseppe Dell’Elba, et al.. (2015). Roflumilast inhibits leukocyte–platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes. Journal of Thrombosis and Haemostasis. 14(1). 191–204. 29 indexed citations
9.
Victoni, Tatiana, Manuella Lanzetti, Hermann Tenor, et al.. (2014). Roflumilast N-Oxide Prevents Cytokine Secretion Induced by Cigarette Smoke Combined with LPS through JAK/STAT and ERK1/2 Inhibition in Airway Epithelial Cells. PLoS ONE. 9(1). e85243–e85243. 34 indexed citations
10.
Vecchio, Daniela, Alessandra Acquaviva, Beatrice Arezzini, et al.. (2013). Downregulation of NOX4 Expression by Roflumilast N-Oxide Reduces Markers of Fibrosis in Lung Fibroblasts. Mediators of Inflammation. 2013. 1–8. 17 indexed citations
11.
Ikari, Jun, Joel Michalski, Shunichiro Iwasawa, et al.. (2013). Phosphodiesterase-4 Inhibition Augments Human Lung Fibroblast Vascular Endothelial Growth Factor Production Induced by Prostaglandin E2. American Journal of Respiratory Cell and Molecular Biology. 49(4). 571–581. 11 indexed citations
12.
Kirschbaum, Andreas, et al.. (2012). Roflumilast-N-oxide Induces Surfactant Protein Expression in Human Alveolar Epithelial Cells Type II. PLoS ONE. 7(7). e38369–e38369. 6 indexed citations
13.
Milara, Javier, M Armengot, Hermann Tenor, et al.. (2012). Roflumilast N‐oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smokein vitro. British Journal of Pharmacology. 166(8). 2243–2262. 73 indexed citations
14.
Schudt, Christian, Armin Hatzelmann, Rolf Beume, & Hermann Tenor. (2011). Phosphodiesterase Inhibitors: History of Pharmacology. Handbook of experimental pharmacology. 1–46. 38 indexed citations
15.
Buenestado, Amparo, Stanislas Grassin‐Delyle, Emmanuel Naline, et al.. (2011). Roflumilast inhibits the release of chemokines and TNF‐α from human lung macrophages stimulated with lipopolysaccharide. British Journal of Pharmacology. 165(6). 1877–1890. 62 indexed citations
16.
Tenor, Hermann, et al.. (2010). Cytokine‐dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition. Journal of Cellular Physiology. 223(2). 317–326. 28 indexed citations
17.
Hatzelmann, Armin, Esteban Morcillo, Giuseppe Lungarella, et al.. (2010). The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 23(4). 235–256. 248 indexed citations
18.
Izikki, Mohamed, Bernadette Raffestin, Armin Hatzelmann, et al.. (2009). Effects of Roflumilast, a Phosphodiesterase-4 Inhibitor, on Hypoxia- and Monocrotaline-Induced Pulmonary Hypertension in Rats. Journal of Pharmacology and Experimental Therapeutics. 330(1). 54–62. 32 indexed citations
19.
Cortijo, Julio, Manuel Mata, Miguel Cerdá‐Nicolás, et al.. (2009). Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin‐induced lung injury. British Journal of Pharmacology. 156(3). 534–544. 96 indexed citations
20.
Sanz, María‐Jesús, Julio Cortijo, May Abu‐Taha, et al.. (2007). Roflumilast inhibits leukocyte‐endothelial cell interactions, expression of adhesion molecules and microvascular permeability. British Journal of Pharmacology. 152(4). 481–492. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rolf Beume Breakdown of academic impact, for papers by Manjula Karpurapu Breakdown of academic impact, for papers by Shinji Sakaue Breakdown of academic impact, for papers by Suchita Singh Breakdown of academic impact, for papers by Zouher Majd Breakdown of academic impact, for papers by Marco Failla Breakdown of academic impact, for papers by Ernst Wm. Spannhake Breakdown of academic impact, for papers by Yunbiao Lu Breakdown of academic impact, for papers by Ayaka Kinoshita Breakdown of academic impact, for papers by Lei Xue
Rankless by CCL
2026